Drug recall
Red Blood Cells
FDA recall event 30192 · Class II · Central Blood Bank
Key facts
| Event ID | 30192 |
|---|---|
| Recall numbers | B-0151-5 |
| Recalling firm | Central Blood Bank |
| Product type | Biologics |
| Products | Red Blood Cells |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood product, manufactured in a manner that may have compromised the sterility of the unit, was distributed. |
| Initiation date | Apr 23, 2004 |
| Termination date | Nov 15, 2004 |
| City | Pittsburgh |
| Country | United States |
| FEI number | 2571073 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports